Resultados de procura - Andreas Reiter

Limitar resultados
  1. 1
    Myeloid neoplasms with eosinophilia

    Myeloid neoplasms with eosinophilia por Andreas Reiter, Jason Gotlib

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis

    New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis por Andreas Reiter, Tracy I. George, Jason Gotlib

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Chronic mast cell leukemia: A novel leukemia-variant with distinct morphological and clinical features

    Chronic mast cell leukemia: A novel leukemia-variant with distinct morphological and clinical features por Peter Valent, Karl Sotlar, Wolfgang R. Sperr, Andreas Reiter, Michel Arock, Hans‐Peter Horny

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches

    Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches por Peter Valent, Cem Akin, Karoline V. Gleixner, Wolfgang R. Sperr, Andreas Reiter, Michel Arock, Massimo Triggiani

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    The serum tryptase test: an emerging robust biomarker in clinical hematology

    The serum tryptase test: an emerging robust biomarker in clinical hematology por Peter Valent, Wolfgang R. Sperr, Karl Sotlar, Andreas Reiter, Cem Akin, Jason Gotlib, Hans-Peter Horny, Michel Arock

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals

    TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals por Andrew Chase, Thomas Ernst, Andreas Fiebig, Andrew Collins, Francis Grand, Philipp Erben, Andreas Reiter, S. Schreiber, Nicholas C.P. Cross

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity

    Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity por Peter Valent, Lina Degenfeld‐Schonburg, Irina Sadovnik, Hans‐Peter Horny, Michel Arock, Hans‐Uwe Simon, Andreas Reiter, Bruce S. Bochner

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas

    Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas por Cécile Meier, Sylvia Hoeller, Caroline Bourgau, Petra Hirschmann, Juerg Schwaller, Philip Went, Stefano Pileri, Andreas Reiter, Stephan Dirnhofer, Alexandar Tzankov

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood

    Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood por Seisho Takeuchi, CR Bartram, Taku Seriu, Miller Cw, A Tobler, JW Janssen, Andreas Reiter, WD Ludwig, Martin Zimmermann, J Schwaller

    Publicado 1995
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis

    Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis por Nicolaus Kröger, Anita Badbaran, Ernst Holler, J. Hahn, Guido Kobbe, Martin Bornhäuser, Andreas Reiter, Tatjana Zabelina, Axel R. Zander, Boris Fehse

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

    The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation por Pia Raanani, Francesco Dazzi, Jastinder Sohal, Richard Szydlo, Frits van Rhee, Andreas Reiter, Feng Lin, J M Goldman, Nicholas C.P. Cross

    Publicado 1997
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Two novel imatinib‐responsive <i>PDGFRA</i> fusion genes in chronic eosinophilic leukaemia

    Two novel imatinib‐responsive <i>PDGFRA</i> fusion genes in chronic eosinophilic leukaemia por Claire Curtis, Francis Grand, Pellegrino Musto, Andrew Clark, John Murphy, Gianni Perla, Maria Marta Minervini, Janet Stewart, Andreas Reiter, Nicholas C.P. Cross

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Treatment-free remission in FIP1L1-PDGFRA–positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation

    Treatment-free remission in FIP1L1-PDGFRA–positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation por Georgia Metzgeroth, Juliana Schwaab, Nicole Naumann, Mohamad Jawhar, Torsten Haferlach, Alice Fabarius, Andreas Hochhaus, Wolf‐Karsten Hofmann, Nicholas C.P. Cross, Andreas Reiter

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia

    A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia por Andreas Hochhaus, Andreas Reiter, Heyko Skladny, JV Melo, C. Sick, Ute Berger, JQ Guo, RB Arlinghaus, R. Hehlmann, JM Goldman, Nicholas C.P. Cross

    Publicado 1996
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study

    Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study por Andreas Hochhaus, Michele Baccarani, Francis J. Giles, Philipp D. le Coutre, Martin Müller, Andreas Reiter, Helene Santanastasio, Mimi Leung, Steven Novick, Hagop M. Kantarjian

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Abnormalities of Chromosome Band 8p11 in Leukemia: Two Clinical Syndromes Can Be Distinguished on the Basis of MOZ Involvement

    Abnormalities of Chromosome Band 8p11 in Leukemia: Two Clinical Syndromes Can Be Distinguished on the Basis of MOZ Involvement por Ricardo C.T. Aguiar, Andrew Chase, Stephanie Coulthard, Donald Macdonald, Melina Carapeti, Andreas Reiter, Jastinder Sohal, Anne Lennard, John M. Goldman, Nicholas C.P. Cross

    Publicado 1997
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

    Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction por Andreas Hochhaus, Feng Lin, Andreas Reiter, Heyko Skladny, PJ Mason, Frits van Rhee, P Shepherd, NC Allan, Rüdiger Hehlmann, JM Goldman, Nicholas C.P. Cross

    Publicado 1996
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms

    Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms por Thomas Ernst, Andrew Chase, Katerina Zoi, Katherine Waghorn, Claire Hidalgo-Curtis, J Score, Amy V. Jones, Francis Grand, Andreas Reiter, Andreas Hochhaus, Nicholas C.P. Cross

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor gene

    Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor gene por Christoph Walz, Georgia Metzgeroth, Claudia Haferlach, Annette Schmitt‐Graeff, Alice Fabarius, Volker Hagen, Otto Prümmer, Stefan Rauh, Rüdiger Hehlmann, Andreas Hochhaus, Nicholas C.P. Cross, Andreas Reiter

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort

    Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort por Georgia Metzgeroth, Laurenz Steiner, Nicole Naumann, Johannes Lübke, Sebastian Kreil, Alice Fabarius, Claudia Haferlach, Torsten Haferlach, Wolf‐Karsten Hofmann, Nicholas C.P. Cross, Juliana Schwaab, Andreas Reiter

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: